Wow over 37000 reads on this thread. having just seen he webinar a think Patterson does read take notice to this board!. IMO a good sales pitch. I am not going to heap on more praise as probably lots have however it is good to be critical facts presented or not presented.
Got the impression VC will be more of supermarket item hopefully they can sell in bulk with small profitability, nice to see him acknowledge lack of communication here- lets see how the next quarters go on that and impact on company profit margin
Europe growth looks very disappointing at 16% would think reg approval for would be more of a priority here. getting over 50% market dominance will be challenge with those growth rates(just look at some of their peers doing good job here). I dont they have luxury as small company of their staff gallabanting & cash burning around exotic markets IMO best focus on investing in high profit US and Europe leave that to big med titans.
nice to see finally they are contemplating IP route on however next stages post protoyyping are where the cash burn will significantly increase and negotiating with the Goliaths edwards) will be tough call so will be interested to see how that develops.
what counts in the end is market response. thats what will make us money, and that appears limited looking at 34c as of today
Ann: Shareholder Webinar, page-214
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |